Abstracts of papers deposited at VINITI

Autor: M. M. Rozenblit, I. P. Raevskii, O. N. Sytova, L. S. Minchenko, M. P. Kovalevskaya, V. A. Kulikov, M. A. Belyaev, V. G. Bagrov, Yu. Yu. Vol'fengaut, S. P. Gavrilov, D. M. Gitman, Sh. M. Shvartsman, I. P. Lukin, V. Ya. Kharanen, Z. N. Esina, E. B. Malets, E. I. Zoz, S. M. Gerasyuta, E. N. Nikitin, S. V. Barbashev, A. A. Vasil'kovskii, T. B. Shashkina, N. V. Dergunova, V. P. Sakhnenko, E. G. Fesenko, V. P. Yakubenko, N. F. Kovalenko, V. P. Morozova, M. I. Lesnaya, B. I. Malinskii, V. F. Nemchenko

Publikováno v: Soviet Physics Journal. 22:221-226

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::23b2ab381e5bdab3e43c69dc687e82f2
https://doi.org/10.1007/bf00892029

Impact of hormone receptor status and tumor subtypes of breast cancer in young BRCA carriers.

Autor: Arecco L; Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genova, Italy; Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (H.U.B), Institut Jules Bordet, Academic Trials Promoting Team, Bruxelles, Belgium. Electronic address: https://twitter.com/Lucarecco., Bruzzone M; U.O. Epidemiologia Clinica, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Bas R; Department of Surgery, Universite Paris Cité, Institut Curie, Paris, France., Kim HJ; Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea., Di Meglio A; Cancer Survivorship Program-Molecular Predicitors and New Targets in Oncology, INSERM Unit 981, Gustave Roussy, Villejuif, France., Bernstein-Molho R; Susanne Levy Gertner Oncogenetics Unit, The Danek Gertner Institute of Human Genetics, Chaim Sheba Medical Center Affiliated to Tel Aviv University, Tel Hashomer, Israel., Hilbers FS; Department of Molecular Pathology, Netherlands Cancer Institute (NKI), Amsterdam, The Netherlands., Pogoda K; Department of Breast Cancer and Reconstructive Surgery, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Carrasco E; Hereditary Cancer Genetics Unit, Medical Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Punie K; Department of General Medical Oncology and Multidisciplinary Breast Center, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium., Bajpai J; Tata Memorial Centre, Homi Bhabha National Institute (HBNI), Mumbai, India., Agostinetto E; Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (H.U.B), Institut Jules Bordet, Academic Trials Promoting Team, Bruxelles, Belgium., Lopetegui-Lia N; Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland., Partridge AH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA., Phillips KA; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia; Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Melbourne, Australia., Toss A; Department of Oncology and Haematology, Azienda Ospedaliero-Universitaria di Modena, Modena; Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy., Rousset-Jablonski C; Department of Surgery, Leon Berard Cancer Centre, Lyon; Unite INSERM U1290 RESHAPE, Claude Bernard Lyon 1 University, Lyon, France; Hôpital Femme Mère Enfant, Hospices civils de Lyon, Bron, France., Curigliano G; European Institute of Oncology, IRCCS, Milan; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Renaud T; Cancer Genetics Unit, Bergonie Institute, Bordeaux, France., Ferrari A; Hereditary Breast and Ovarian Cancer (HBOC) Unit and General Surgery 3-Senology, Surgical Department, Fondazione IRCCS Policlinico San Matteo, Pavia; University of Pavia, Pavia, Italy., Paluch-Shimon S; Breast Oncology Unit, Sharett Institute of Oncology, Hadassah University Hospital, Faculty of Medicine, Hebrew University, Jerusalem, Israel., Fruscio R; U.O. Gynecology, Department of Medicine and Surgery, University of Milan-Bicocca, IRCCS San Gerardo dei Tintori, Monza, Italy., Cui W; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia., Wong SM; Stroll Cancer Prevention Centre and Jewish General Hospital Department of Surgery and Oncology, McGill University Medical School, Montreal, Canada., Vernieri C; Medical Oncology Department, Breast Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan; Oncology and Hematology-Oncology Department, University of Milan, Milan, Italy., Couch FJ; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, USA., Dieci MV; Dipartimento di Scienze Chirurgiche, Oncologiche e Gastroenterologiche, Università di Padova, Padova; Oncologia 2, Istituto Oncologico Veneto IOV-IRCCS, Padova, Italy., Matikas A; Department of Oncology/Pathology, Karolinska Institute and Breast Center, Karolinska University Hospital, Stockholm, Sweden., Rozenblit M; Department of Medical Oncology, Yale University, New Haven, USA., Aguilar-Y Méndez D; Tecnologico de Monterrey, Breast Cancer Center, Hospital Zambrano Hellion-TecSalud, Monterrey, Mexico., De Marchis L; Division of Medical Oncology, Department of Radiological, Oncological and Pathological Sciences, 'La Sapienza' University of Rome, Rome; Oncology Unit, Department of Hematology, Oncology and Dermatology, Umberto I Policlinico di Roma, Rome., Puglisi F; Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano; Department of Medicine, University of Udine, Udine., Fabi A; Precision Medicine Unit in Senology, Scientific Directorate, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome, Italy., Graff SL; Lifespan Cancer Institute, Legorreta Cancer Center at Brown University, Providence, USA., Witzel I; Department of Gynaecology, University Medical Center Hamburg, Hamburg, Germany; Department of Gynecology, University of Zurich, Zurich, Switzerland., Rodriguez Hernandez A; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; Cancer Institute and Blood Diseases, Hospital Clinic de Barcelona, Barcelona, Spain., Fontana A; U.O. Oncologia Medica 2 Universitaria, Azienda Ospedaliero Universitaria Pisana, Ospedale Santa Chiara, Pisa, Italy., Pesce R; Reproductive medicine, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina., Duchnowska R; Department of Oncology, Military Institute of Medicine, National Research Institute, Warsaw, Poland., Pais HL; Department of Medical Oncology, Centro Hospitalar Universitário Lisboa Norte-Hospital de Santa Maria, Lisbon, Portugal., Sini V; Medical Oncology, Centro Oncologico Santo Spirito-Nuovo Regina Margherita, ASL Roma 1, Rome, Italy., Sokolović E; Oncology Clinic, Clinical Center University of Sarajevo, Sarajevo, Bosnia and Herzegovina., de Azambuja E; Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (H.U.B), Institut Jules Bordet, Academic Trials Promoting Team, Bruxelles, Belgium., Ceppi M; U.O. Epidemiologia Clinica, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Blondeaux E; U.O. Epidemiologia Clinica, IRCCS Ospedale Policlinico San Martino, Genova, Italy. Electronic address: https://twitter.com/BlondeauxEva., Lambertini M; Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genova, Italy; Medical Oncology Department, U.O.C. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy. Electronic address: matteo.lambertini@unige.it.

Publikováno v: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2024 Sep; Vol. 35 (9), pp. 792-804. Date of Electronic Publication: 2024 Jun 20.

Transition from methotrexate and cyclosporine to other therapies including retinoids, ultraviolet light and biologic agents in the management of patients with psoriasis.

Autor: Maryles S; Department of Dermatology, Mount Sinai School of Medicine, 1 Gustave Levy Place, New York, NY 10029-6574, USA., Rozenblit M, Lebwohl M

Publikováno v: The Journal of dermatological treatment [J Dermatolog Treat] 2003; Vol. 14 Suppl 2, pp. 7-16.